Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S10.18
P/E—
Fwd P/E20.72
PEG0.88
52W— – —
RSI—
Target$244.14 (+17.4%)
Beta0.94
Div—
Loading chart…
RSI (14)
Loading patterns…
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 67
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
2Bullish
0Bearish
0Neutral
▲ Double Bottom — Two lows ~$152.56 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$152.70 — bullish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$244.14
+17.4% upside
Low $165
—
High $350
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Guggenheim | Buy | — | ● Initiate | 2026-07-23 |
| Citigroup | Neutral | — | ↔ Maintain | 2026-06-04 |
| Mizuho | Outperform | — | ↔ Maintain | 2026-06-04 |
| Goldman Sachs | Sell | — | ↔ Maintain | 2026-06-04 |
| Oppenheimer | Outperform | — | ↔ Reiterate | 2026-06-04 |
| Canaccord Genuity | Hold | — | ↔ Maintain | 2026-06-04 |
| Stifel | Buy | — | ↔ Maintain | 2026-06-04 |
| Evercore ISI Group | In-Line | — | ↔ Maintain | 2026-06-04 |
| UBS | Neutral | — | ↔ Maintain | 2026-06-04 |
| RBC Capital | Outperform | — | ↔ Reiterate | 2026-06-04 |
| BMO Capital | Market Perform | — | ↔ Maintain | 2026-06-04 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-06-04 |
| Barclays | Overweight | — | ↔ Maintain | 2026-06-04 |
| Baird | Outperform | — | ↔ Maintain | 2026-06-04 |
| BTIG | Buy | — | ↔ Reiterate | 2026-06-04 |
| Needham | Buy | — | ↔ Reiterate | 2026-06-04 |
| Piper Sandler | Overweight | — | ↔ Maintain | 2026-06-04 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-03-05 |
| Truist Securities | Buy | — | ↔ Reiterate | 2026-03-05 |
| Morgan Stanley | Equal-Weight | — | ↔ Maintain | 2026-03-05 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-02-20 |
| Keybanc | Sector Weight | Overweight → Sector Weight | ▼ Downgrade | 2025-12-12 |
Guggenheim
2026-07-23
Buy
● Initiate
Citigroup
2026-06-04
Neutral
↔ Maintain
Mizuho
2026-06-04
Outperform
↔ Maintain
Goldman Sachs
2026-06-04
Sell
↔ Maintain
Oppenheimer
2026-06-04
Outperform
↔ Reiterate
Canaccord Genuity
2026-06-04
Hold
↔ Maintain
Stifel
2026-06-04
Buy
↔ Maintain
Evercore ISI Group
2026-06-04
In-Line
↔ Maintain
UBS
2026-06-04
Neutral
↔ Maintain
RBC Capital
2026-06-04
Outperform
↔ Reiterate
BMO Capital
2026-06-04
Market Perform
↔ Maintain
Wells Fargo
2026-06-04
Overweight
↔ Maintain
Barclays
2026-06-04
Overweight
↔ Maintain
Baird
2026-06-04
Outperform
↔ Maintain
BTIG
2026-06-04
Buy
↔ Reiterate
Needham
2026-06-04
Buy
↔ Reiterate
Piper Sandler
2026-06-04
Overweight
↔ Maintain
TD Cowen
2026-03-05
Buy
↔ Maintain
Truist Securities
2026-03-05
Buy
↔ Reiterate
Morgan Stanley
2026-03-05
Equal-Weight
↔ Maintain
JP Morgan
2026-02-20
Overweight
↔ Maintain
Keybanc
2025-12-12
Sector Weight
(from Overweight)
▼ Downgrade
Profitability
Gross Margin
75.02%TTM
Op. Margin
30.93%TTM
ROE
13.93%TTM
Rev. Growth
16.30%YoY
Free Cash Flow
1.26BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
1.41MRQ
Current Ratio
4.74MRQ
Cash
7.31BMRQ
Total Debt
103.07MMRQ
Net Debt
—MRQ
How VEEV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 33.77B |
| Enterprise Value | 26.56B |
| Trailing P/E | 35.72 |
| Forward P/E | 20.72 |
| PEG Ratio (5yr) | 0.88 |
| Price/Sales (ttm) | 10.18 |
| Price/Book (mrq) | 4.64 |
| EV/Revenue | 8.00 |
| EV/EBITDA | 25.89 |
Share Statistics
| Avg Vol (3m) | 3.06M |
| Shares Outstanding | 162.44M |
| Float | 148.91M |
| % Held by Insiders | 8.58% |
| % Held by Institutions | 89.77% |
| Short Ratio | 3.17 |
| Short % of Float | 5.33% |
Profitability
| Gross Margin | 75.02% |
| Operating Margin (ttm) | 30.93% |
| Profit Margin | 28.37% |
| Return on Assets (ttm) | 7.30% |
| Return on Equity (ttm) | 13.93% |
Income Statement
| Revenue (ttm) | 3.32B |
| Revenue Growth (yoy) | 16.30% |
| Gross Profit (ttm) | 2.49B |
| EBITDA | 1.03B |
| Net Income (ttm) | 941.65M |
| Diluted EPS (ttm) | 5.82 |
| EPS Growth (yoy) | 14.60% |
Balance Sheet
| Total Cash (mrq) | 7.31B |
| Total Debt (mrq) | 103.07M |
| Debt / Equity (mrq) | 1.41 |
| Current Ratio (mrq) | 4.74 |
| Book Value / Share | 44.83 |
| Operating CF (ttm) | 1.67B |
| Free Cash Flow (ttm) | 1.26B |
Trading & Dividends
| Beta (5Y) | 0.94 |
| 50-Day MA | 176.50 |
| 200-Day MA | 204.71 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 89.77%
Insider 8.58%
Public 1.7%
Short Interest
5.33% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in VEEV in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | SCHWENGER THOMAS D | President | Sale at price 200.00 per share. | 5,000 | $1,000,000 |
| 2026-07-01 | ZUPPAS ELENI NITSA A | President | 2,180 | — | |
| 2026-07-01 | VAN WAGENER BRIAN | Chief Financial Officer | 1,635 | — | |
| 2026-07-01 | KONDATH VIPIN | Officer | 167 | — | |
| 2026-07-01 | SCHWENGER THOMAS D | President | 2,907 | — | |
| 2026-07-01 | FADDIS JONATHAN W | General Counsel | 1,635 | — | |
| 2026-06-01 | SEKHRI PAUL JAI | Director | 253 | — | |
| 2026-06-01 | MOHR MARSHALL L | Director | 289 | — | |
| 2026-06-01 | CARGES MARK T | Director | 271 | — | |
| 2026-06-01 | HEDLEY MARY LYNNE | Director | 262 | — | |
| 2026-06-01 | RITTER GORDON | Director | 298 | — | |
| 2026-06-01 | CABRAL TIMOTHY S | Director | 262 | — | |
| 2026-06-01 | WALLACH MATTHEW J | Director | 253 | — | |
| 2026-06-01 | HUNG PRISCILLA C | Director | 262 | — | |
| 2026-04-30 | HUNG PRISCILLA C | Director | Sale at price 155.64 per share. | 750 | $116,730 |
| 2026-04-10 | HUNG PRISCILLA C | Director | Sale at price 153.50 per share. | 750 | $115,125 |
| 2026-04-01 | ZUPPAS ELENI NITSA A | President | 8,998 | — | |
| 2026-04-01 | VAN WAGENER BRIAN | Chief Financial Officer | 872 | — | |
| 2026-04-01 | KONDATH VIPIN | Officer | 2,603 | — | |
| 2026-04-01 | SCHWENGER THOMAS D | President | 2,043 | — | |
| 2026-04-01 | FADDIS JONATHAN W | General Counsel | 8,726 | — | |
| 2026-03-05 | SCHWENGER THOMAS D | President | Sale at price 200.00 per share. | 1,000 | $200,000 |
| 2026-02-27 | SEKHRI PAUL JAI | Director | 253 | — | |
| 2026-02-27 | MOHR MARSHALL L | Director | 288 | — | |
| 2026-02-27 | CARGES MARK T | Director | 271 | — |
SCHWENGER THOMAS D
President
Sale at price 200.00 per share.
2026-07-16
5,000 sh
$1,000,000
ZUPPAS ELENI NITSA A
President
2026-07-01
2,180 sh
—
VAN WAGENER BRIAN
Chief Financial Officer
2026-07-01
1,635 sh
—
KONDATH VIPIN
Officer
2026-07-01
167 sh
—
SCHWENGER THOMAS D
President
2026-07-01
2,907 sh
—
FADDIS JONATHAN W
General Counsel
2026-07-01
1,635 sh
—
SEKHRI PAUL JAI
Director
2026-06-01
253 sh
—
MOHR MARSHALL L
Director
2026-06-01
289 sh
—
CARGES MARK T
Director
2026-06-01
271 sh
—
HEDLEY MARY LYNNE
Director
2026-06-01
262 sh
—
RITTER GORDON
Director
2026-06-01
298 sh
—
CABRAL TIMOTHY S
Director
2026-06-01
262 sh
—
WALLACH MATTHEW J
Director
2026-06-01
253 sh
—
HUNG PRISCILLA C
Director
2026-06-01
262 sh
—
HUNG PRISCILLA C
Director
Sale at price 155.64 per share.
2026-04-30
750 sh
$116,730
HUNG PRISCILLA C
Director
Sale at price 153.50 per share.
2026-04-10
750 sh
$115,125
ZUPPAS ELENI NITSA A
President
2026-04-01
8,998 sh
—
VAN WAGENER BRIAN
Chief Financial Officer
2026-04-01
872 sh
—
KONDATH VIPIN
Officer
2026-04-01
2,603 sh
—
SCHWENGER THOMAS D
President
2026-04-01
2,043 sh
—
FADDIS JONATHAN W
General Counsel
2026-04-01
8,726 sh
—
SCHWENGER THOMAS D
President
Sale at price 200.00 per share.
2026-03-05
1,000 sh
$200,000
SEKHRI PAUL JAI
Director
2026-02-27
253 sh
—
MOHR MARSHALL L
Director
2026-02-27
288 sh
—
CARGES MARK T
Director
2026-02-27
271 sh
—